What Does Your AMH Really Mean? An Integrative Fertility Physician Explains Anti-Müllerian Hormone, Egg Quality, and Your Fertility

What Does Your AMH Really Mean?

One of the most common statements I hear from patients is:

“My AMH is low. Does that mean I can’t get pregnant?”

Receiving an Anti-Müllerian Hormone (AMH) result that is lower than expected can be frightening. Many women immediately assume that a low AMH means they have poor-quality eggs, cannot conceive naturally, or have little chance of success with fertility treatment. Fortunately, that is rarely the complete picture.

Likewise, women with a high AMH—especially those diagnosed with polycystic ovary syndrome (PCOS)—often wonder whether a higher number automatically means they are more fertile. The answer is more nuanced than many people realize.

Whether your AMH is lower than expected, higher because of a condition such as PCOS, or somewhere in between, understanding what this hormone can—and cannot—tell you is essential for making informed decisions about your fertility.

AMH has become one of the most valuable laboratory tests available for evaluating ovarian reserve, yet it is also one of the most misunderstood. While AMH provides important information about the estimated number of remaining eggs, it does not directly measure egg quality, your ability to become pregnant naturally, or whether you will ultimately have a healthy baby.

As an integrative fertility physician, I believe laboratory testing should never be interpreted in isolation. Your age, menstrual history, hormone balance, ultrasound findings, thyroid health, nutritional status, metabolic health, lifestyle habits, environmental exposures, genetics, and your partner’s fertility all contribute to the bigger picture.

One laboratory value should never define your fertility journey.

Understanding what AMH truly measures—and what it does not—can help replace fear with knowledge and allow you and your healthcare team to focus on the factors that can often be improved.

What Is AMH?

Anti-Müllerian Hormone (AMH) is a protein hormone produced by the granulosa cells that surround small developing follicles within the ovaries. These early follicles contain immature eggs that may eventually mature and ovulate during future menstrual cycles.

Think of AMH as a reflection of the number of small growing follicles present in your ovaries at a given time.

Because these follicles contain immature eggs, AMH correlates with ovarian reserve—the estimated number of eggs remaining—but it does not count eggs directly and it does not measure the health or quality of those eggs.

Women are born with all of the eggs they will ever have. Before birth, the ovaries contain several million immature eggs. By puberty, that number has declined to approximately 300,000 to 500,000. Throughout the reproductive years, hundreds of follicles begin developing each month, but usually only one reaches ovulation while the others naturally undergo a process called atresia.

As this follicle pool gradually declines with age, AMH levels generally decline as well.

Because of this relationship, AMH has become an important marker for estimating ovarian reserve and predicting how the ovaries may respond to stimulation during in vitro fertilization (IVF). However, AMH should never be viewed as a predictor of whether someone can or cannot become pregnant.

Many women with low AMH conceive naturally, while others with normal or high AMH may still experience infertility for entirely different reasons.

How Is AMH Measured?

AMH is measured through a simple blood test.

Unlike follicle-stimulating hormone (FSH) and estradiol, which are typically measured early in the menstrual cycle, AMH remains relatively stable throughout the month. Because of this, it can usually be drawn on almost any day of the menstrual cycle.

One of the greatest strengths of AMH testing is its convenience. However, convenience should not be confused with certainty.

AMH provides only one piece of the fertility puzzle.

In my practice, I rarely interpret AMH by itself. Instead, I evaluate it alongside several additional factors, including:

• Age
• Menstrual history
• Antral Follicle Count (AFC) on ultrasound
• FSH
• LH
• Estradiol
• Progesterone
• Thyroid function
• Vitamin D
• Iron status
• Metabolic health
• Lifestyle factors
• Male fertility evaluation when appropriate

For example, an AMH level that may be expected in a healthy 41-year-old woman could be concerning in someone who is only 28 years old. Likewise, a woman with a low AMH but an excellent antral follicle count and otherwise reassuring laboratory findings may have a very different prognosis than someone with additional fertility challenges.

This is why age-specific interpretation is essential.

Laboratories provide reference ranges, but those numbers should always be interpreted within the context of your overall reproductive health.

Can AMH Fluctuate?

One of the most common questions patients ask is:

“Should I repeat my AMH? Could it change?”

The answer is yes—but usually not dramatically.

For many years, AMH was believed to remain almost completely stable throughout the menstrual cycle. More recent research suggests that while AMH is generally more consistent than many reproductive hormones, modest fluctuations can occur.

Several factors may influence AMH measurements, including:

• Differences between laboratory testing methods
• Vitamin D deficiency
• Hormonal contraceptive use
• Pregnancy
• Recent ovarian surgery
• Certain medical treatments
• Normal biological variation

Because of these factors, a single AMH result should never be interpreted in isolation, particularly if it does not match the overall clinical picture.

If an unexpected result is obtained, repeating the test several months later—especially after correcting significant vitamin D deficiency or discontinuing hormonal contraception when medically appropriate—may provide additional information.

It is also important to remember that AMH naturally declines over time.

A gradual decrease is a normal part of reproductive aging and should not automatically be interpreted as a sign that pregnancy is impossible.

Rather than focusing on one isolated laboratory value, I encourage patients to ask a better question:

“What does this result mean for me, given my age, my health, my ultrasound findings, and my overall fertility picture?”

That is where AMH becomes truly valuable.

What Can Affect AMH?

Although AMH naturally declines as women age, several other factors may influence AMH levels and ovarian reserve. Some of these are simply part of biology, while others may represent medical conditions or lifestyle factors that deserve further evaluation.

Understanding these influences can help you and your healthcare provider better interpret your results and determine whether additional testing or treatment may be appropriate.

Age

Age remains the single most important factor affecting ovarian reserve.

Women are born with all of the eggs they will ever have. Unlike other cells in the body, new eggs are not produced throughout life. Instead, the pool of available eggs gradually declines from before birth until menopause.

For most women, AMH begins to slowly decline during the early thirties, with a more rapid decline often occurring after age 35. Egg quality also decreases with age because chromosomes within the eggs become more prone to errors during cell division.

While AMH estimates egg quantity, age remains one of the strongest predictors of egg quality.

This is one reason why two women with identical AMH levels may have very different fertility outcomes depending on their age.

Genetics

Some women simply inherit a tendency toward earlier ovarian aging.

If your mother or sisters experienced menopause at an unusually young age, this may provide clues about your own reproductive timeline.

Researchers continue to identify genes involved in ovarian development and follicle depletion. While genetics cannot currently be changed, understanding your family history may help guide fertility planning.

This is another reminder that AMH should always be interpreted within the context of your personal medical history.

Endometriosis

Endometriosis is a chronic inflammatory condition in which tissue similar to the uterine lining grows outside the uterus.

When endometriosis involves the ovaries—particularly ovarian endometriomas—it may reduce ovarian reserve.

Both the disease itself and surgical treatment of ovarian endometriomas have been associated with lower AMH levels in some women.

This does not mean surgery should never be performed. Rather, surgical decisions should carefully balance symptom relief, preservation of ovarian tissue, and future fertility goals.

Ovarian Surgery

Any surgery involving the ovaries has the potential to remove or damage healthy ovarian tissue.

Procedures for ovarian cysts, endometriomas, or other ovarian masses may reduce AMH because some normal follicles are unavoidably removed during surgery.

Whenever fertility preservation is important, discussing surgical technique and ovarian preservation with your surgeon beforehand is worthwhile.

Chemotherapy and Radiation

Certain chemotherapy medications and pelvic radiation treatments can significantly reduce ovarian reserve because they may damage developing follicles.

Women diagnosed with cancer who hope to have children in the future should discuss fertility-preservation options before beginning treatment whenever possible.

Egg freezing, embryo freezing, or ovarian tissue preservation may be appropriate depending on the individual’s age and clinical circumstances.

Smoking

Smoking remains one of the strongest modifiable lifestyle factors associated with accelerated ovarian aging.

Tobacco smoke contains numerous toxins that increase oxidative stress within the ovaries and may accelerate follicular depletion.

Studies have demonstrated that women who smoke often have lower AMH levels than nonsmokers and may experience menopause earlier in life.

The good news is that smoking cessation provides benefits far beyond fertility, improving overall reproductive health, pregnancy outcomes, cardiovascular health, and long-term wellness.

Obesity

Obesity does not directly determine fertility, but it can influence reproductive hormones, inflammation, insulin sensitivity, and ovarian function.

Research evaluating the relationship between obesity and AMH has produced mixed results, with some studies reporting lower AMH concentrations among women with obesity and others showing little difference after adjusting for age.

Regardless of AMH, achieving a healthier body weight when appropriate may improve ovulation, metabolic health, and reproductive outcomes.

The goal should never be perfection. Even modest improvements in nutrition, physical activity, and metabolic health may positively influence reproductive function.

What Doesn’t Lower AMH?

Patients are often relieved to learn that many commonly feared situations do not permanently lower AMH.

Low AMH is not caused by:

• One stressful month
• Working too hard
• Poor sleep for a few weeks
• One unhealthy diet
• Traveling
• Regular exercise
• Sexual activity
• Temporary emotional stress

Likewise, a low AMH level does not automatically mean:

• You cannot become pregnant naturally.
• Your eggs are poor quality.
• IVF will not work.
• You are entering menopause immediately.
• You should give up hope.

AMH represents one laboratory measurement—not your fertility destiny.

Can Anything Improve Egg Quality Even if AMH Stays the Same?

This is perhaps the question I am asked most frequently.

Current research has not demonstrated that supplements or lifestyle changes reliably increase the number of eggs remaining within the ovaries.

In other words, we cannot currently “grow new eggs.”

However, emerging evidence suggests we may be able to improve the environment in which eggs mature.

That distinction is incredibly important.

Egg quality is influenced by factors including mitochondrial function, oxidative stress, inflammation, hormone balance, metabolic health, and adequate nutrition.

While your AMH may remain unchanged, optimizing these factors may help support the health and developmental potential of the eggs you already have.

Vitamin D

Vitamin D deficiency is extremely common among women of reproductive age.

Some studies suggest correcting vitamin D deficiency may influence AMH levels, although findings remain inconsistent.

More importantly, vitamin D plays important roles in immune regulation, ovarian function, and reproductive health.

Rather than supplementing blindly, I generally recommend testing vitamin D levels and individualizing supplementation based on laboratory results.

Coenzyme Q10 (CoQ10)

Coenzyme Q10 has become one of the most widely discussed supplements in fertility medicine.

CoQ10 supports mitochondrial energy production. Because developing eggs have substantial energy requirements, mitochondrial function is important for chromosome separation, fertilization, embryo development, and healthy cell division.

Several studies suggest CoQ10 supplementation may improve ovarian response and some embryologic outcomes in selected women with diminished ovarian reserve.

Although CoQ10 has not consistently been shown to increase AMH itself, the goal of using it is generally to support egg quality rather than change the AMH number.

DHEA

DHEA (dehydroepiandrosterone) has been studied primarily in women with diminished ovarian reserve undergoing fertility treatment.

Some studies have suggested potential improvements in ovarian response or reproductive outcomes in selected patients, but results across studies remain mixed.

DHEA is not appropriate for everyone.

Because DHEA may increase androgen levels and contribute to acne, unwanted hair growth, mood changes, or elevated testosterone, supplementation should be considered only after appropriate evaluation and preferably under medical supervision.

Lifestyle Matters

Egg development is a lengthy process occurring over several months before ovulation. This means that the environment in which an egg develops may be influenced by health and lifestyle during the months leading up to ovulation.

Although no lifestyle program can reverse reproductive aging, healthy habits may help reduce inflammation and oxidative stress while supporting overall reproductive health.

These include:

• Eating a Mediterranean-style diet rich in colorful vegetables, healthy fats, lean proteins, and whole foods.
• Exercising regularly without excessive overtraining.
• Maintaining a healthy body weight when appropriate.
• Getting adequate, consistent sleep.
• Managing chronic stress.
• Avoiding smoking and limiting excessive alcohol consumption.

Small, sustainable changes practiced consistently often provide greater long-term benefits than extreme short-term programs.

Acupuncture

Acupuncture has been used for centuries to support reproductive health and is now commonly incorporated into integrative fertility care. While acupuncture cannot restore the natural loss of eggs that occurs with age, research suggests that its potential fertility benefits extend beyond simply reducing stress.

Studies have investigated acupuncture for its effects on ovarian function, reproductive hormones, endometrial receptivity, ovarian response, and IVF outcomes. In women with diminished ovarian reserve, a systematic review and meta-analysis of randomized controlled trials found improvements in FSH, antral follicle count (AFC), and a small improvement in AMH compared with control groups, although there was substantial variability among the studies.

Acupuncture has also been studied as an adjunct to IVF. Recent systematic reviews and meta-analyses have reported improvements in clinical pregnancy and, in some analyses, live birth rates. The results appear to vary depending on factors such as when acupuncture is performed, the number of treatments, the acupuncture protocol, and the comparison group used, which may help explain why earlier research produced conflicting results.

Another area of interest is the uterine environment and endometrial receptivity. Research has examined whether acupuncture may influence factors related to endometrial blood flow, endometrial thickness, implantation, and receptivity. An overview published in 2025 found signals of benefit for endometrial receptivity and pregnancy outcomes, but also emphasized that much of the existing evidence was low or very low quality and that better-designed trials are still needed.

Importantly, acupuncture should not be presented as a treatment that reliably raises AMH or restores ovarian reserve. Some studies have reported modest improvements in AMH and other ovarian reserve markers in women with diminished ovarian reserve or premature ovarian insufficiency, but the evidence is not yet strong enough to conclude that acupuncture increases the underlying number of eggs remaining.

From an integrative fertility perspective, I use acupuncture as one component of a broader treatment plan. Depending on the individual, the goals may include supporting ovarian function, hormone regulation, uterine and endometrial health, stress reduction, and fertility treatment outcomes rather than trying to change a single laboratory number.

Genetics, MTHFR, and Environmental Toxins

Genetics influence many aspects of reproductive health, including ovarian reserve, reproductive lifespan, and potentially egg quality.

Certain genetic variants, including MTHFR polymorphisms, can influence folate metabolism. However, the presence of an MTHFR variant alone does not establish a cause of infertility, and routine MTHFR testing is not recommended for every fertility patient.

Environmental exposures have also become an important area of reproductive research.

Chemicals such as bisphenol A (BPA), phthalates, certain pesticides, and other endocrine-disrupting compounds are being studied for their potential effects on reproductive hormones, oxidative stress, and ovarian function.

It is impossible—and unnecessary—to eliminate every environmental exposure. Practical ways to reduce unnecessary exposure may include:

• Choosing glass or stainless-steel food containers when practical.
• Avoiding heating food in plastic containers.
• Reducing unnecessary exposure to heavily fragranced products.
• Washing fruits and vegetables thoroughly.
• Choosing whole foods more often and reducing heavily packaged foods when practical.

The goal is not perfection or fear. It is simply to reduce avoidable exposures where doing so is realistic.

A Special Note About PCOS and High AMH

While much of this article has focused on low AMH, it is equally important to understand that higher is not always better.

Women with polycystic ovary syndrome (PCOS) often have AMH levels that are higher than average because they typically have a larger number of small follicles within their ovaries. Since these follicles produce Anti-Müllerian Hormone, having more small follicles can result in higher AMH concentrations.

At first glance, this may sound reassuring. However, a higher AMH does not necessarily mean fertility will be easier.

Many women with PCOS have a strong ovarian reserve but experience irregular ovulation or may not ovulate consistently each month. In these cases, the challenge is often ovulation and egg maturation rather than the number of eggs available.

AMH alone should not be used to diagnose PCOS. Healthcare providers consider menstrual and ovulatory patterns, signs or laboratory evidence of androgen excess, and ovarian morphology or AMH where appropriate, while excluding other conditions that can produce similar symptoms.

From an integrative fertility perspective, the goal is not simply to lower an elevated AMH number. The focus is on supporting regular ovulation, metabolic health, hormone balance, and overall reproductive health.

Depending on the individual, this may include nutrition, regular exercise, improving insulin sensitivity, achieving a healthier weight when appropriate, correcting nutrient deficiencies, targeted supplementation, acupuncture, and medications or ovulation-induction therapy when indicated.

The goal is never simply to treat a laboratory number. It is to understand what that number means within the larger fertility picture and determine what, if anything, can be improved.

When Should Someone Worry About a Low AMH?

Receiving a low AMH result should not cause panic, but it should prompt a thoughtful conversation with your healthcare provider.

AMH is most helpful when interpreted alongside your age, menstrual history, ultrasound findings, hormone testing, and reproductive goals. For some women, a lower AMH simply reflects normal reproductive aging. For others—particularly younger women—it may indicate diminished ovarian reserve and deserve further evaluation.

Consider a more comprehensive fertility evaluation if you:

• Are under age 35 and have been trying to conceive for one year without success.
• Are age 35 or older and have been trying for six months without success.
• Are over age 40 and are trying to conceive.
• Have irregular or absent menstrual cycles.
• Have experienced recurrent pregnancy loss.
• Have endometriosis.
• Have undergone ovarian surgery.
• Have a family history of early menopause or primary ovarian insufficiency.
• Have received chemotherapy or pelvic radiation.
• Have an AMH level that appears unexpectedly low for your age.
• Are considering delaying pregnancy and want to better understand your reproductive timeline.

Earlier evaluation can provide more options—not necessarily because something is wrong, but because it allows you to make informed decisions while time and options may be on your side.

One of the greatest advantages of fertility testing is the opportunity to be proactive rather than reactive.

Questions to Ask Your Doctor About Your AMH

If you’ve recently had your AMH tested, consider asking your healthcare provider:

• Is my AMH appropriate for my age?
• How does my AMH compare with my antral follicle count (AFC)?
• Should my AMH be repeated?
• How do my FSH, LH, and estradiol levels fit into the picture?
• Am I ovulating regularly?
• Is my thyroid functioning appropriately for fertility?
• Should my vitamin D level be checked?
• Are there nutritional or metabolic factors that could be affecting my reproductive health?
• Would CoQ10 or other targeted supplementation be appropriate for me?
• Is DHEA appropriate—or inappropriate—in my particular situation?
• Could acupuncture be beneficial as part of my fertility plan?
• Should my partner have a semen analysis or additional male fertility testing?
• Are there additional tests that would help complete my fertility evaluation?
• If I am not ready to conceive now, should I consider fertility preservation?

The goal is not simply to understand your AMH number. It is to understand what that number means for you and what you can reasonably do with that information.

Frequently Asked Questions About AMH

Can I get pregnant naturally with low AMH?

Yes. Many women with low AMH conceive naturally.

AMH primarily reflects ovarian reserve. It does not tell us whether you will ovulate a healthy egg in a particular month, whether sperm will fertilize that egg, or whether an embryo will implant.

Age, ovulation, sperm quality, fallopian-tube health, uterine health, endometrial receptivity, and many other factors contribute to the ability to conceive.

Low AMH may indicate that the reproductive window is becoming shorter, but it does not mean natural pregnancy is impossible.

Does low AMH mean I have poor-quality eggs?

Not necessarily.

AMH primarily provides information about ovarian reserve, or egg quantity—it does not directly measure egg quality.

Age, however, is an important part of the picture. As women get older, both ovarian reserve and egg quality generally decline. Therefore, an older woman with a low AMH is more likely to also have age-related changes in egg quality. In contrast, a younger woman with a low AMH may have fewer eggs remaining but still have relatively good-quality eggs.

This is why AMH should never be interpreted alone. AMH helps us understand egg quantity, while age remains one of the strongest predictors of egg quality. Together with antral follicle count, reproductive history, and other fertility factors, they provide a much more complete picture.

Can AMH increase?

Sometimes AMH measurements increase modestly when repeated, but that does not necessarily mean the ovaries have produced new eggs.

Differences between laboratories, biological variation, hormonal contraception, vitamin D status, and other factors can influence AMH measurements.

Some interventions—including vitamin D correction in deficient women and acupuncture in certain diminished-ovarian-reserve populations—have been associated with changes in AMH in some studies. However, the evidence does not demonstrate that these interventions create new eggs or reverse the underlying age-related decline in ovarian reserve.

This distinction is important: changing an AMH measurement is not necessarily the same thing as increasing the actual number of eggs remaining.

Does birth control lower AMH?

Hormonal contraception can temporarily suppress AMH and antral follicle count in some women.

This can be especially important when AMH is being tested to evaluate ovarian reserve or for fertility-preservation planning. If an AMH result appears unexpectedly low while using hormonal contraception, your healthcare provider may recommend repeating the assessment after discontinuation when medically appropriate.

This effect does not appear to mean that birth control has permanently depleted the egg supply.

Is a high AMH always good?

No.

Women with PCOS frequently have elevated AMH because they have a greater number of small follicles producing Anti-Müllerian Hormone.

This can reflect a strong ovarian reserve, but it does not necessarily translate into easier conception. Women with PCOS may have irregular or absent ovulation, insulin resistance, androgen excess, or other hormonal and metabolic factors that interfere with fertility.

More follicles do not automatically mean better fertility.

Does AMH predict IVF success?

AMH can be very useful for predicting ovarian response to stimulation—in other words, approximately how the ovaries may respond to fertility medications and how many eggs might potentially be retrieved.

It is much less useful as a stand-alone predictor of whether an individual woman will ultimately achieve a pregnancy or live birth.

Egg quality, age, sperm quality, embryo development, genetic factors, uterine receptivity, and many other variables affect IVF success.

Should I repeat my AMH?

Sometimes.

If the AMH result does not fit your age, menstrual history, antral follicle count, or overall clinical picture, repeating it may be reasonable.

The decision should be individualized rather than repeatedly checking AMH simply to watch the number.

The Bottom Line: Your AMH Is Information, Not Your Fertility Destiny

AMH is one of the most useful tools available for estimating ovarian reserve, but it is only one piece of a much larger fertility picture.

It can help us understand approximately how many follicles remain and how the ovaries may respond to fertility treatment.

It cannot tell us everything.

AMH does not directly tell us:

• The quality of your eggs.
• Whether you will conceive naturally.
• Whether a particular egg will fertilize.
• Whether an embryo will implant.
• Whether you will have a healthy pregnancy.

As an integrative fertility physician, I encourage patients to look beyond a single laboratory value.

Your age, ovarian reserve, ovulation, hormone balance, thyroid function, nutritional status, metabolic health, lifestyle, environmental exposures, uterine health, fallopian tubes, and your partner’s fertility all contribute to the larger picture.

While we cannot currently stop ovarian aging or reliably restore the natural loss of eggs, there are often areas of reproductive health that can be addressed.

We can identify nutrient deficiencies.

We can address thyroid and metabolic abnormalities.

We can stop smoking.

We can improve nutrition and lifestyle.

We can reduce unnecessary environmental exposures.

We can support mitochondrial health.

We can evaluate male fertility.

We can use acupuncture when appropriate as part of an integrative fertility plan.

And when necessary, we can involve reproductive endocrinology and fertility-preservation treatments rather than losing valuable time.

The goal isn’t to chase a perfect AMH number.

The goal is to understand your individual fertility picture, identify the factors that can be improved, and make informed decisions based on the information you have today.

Key Takeaways

• AMH estimates ovarian reserve—it does not directly measure egg quality.
• Low AMH does not automatically mean you cannot conceive naturally or have a healthy pregnancy.
• High AMH is commonly seen in women with polycystic ovary syndrome (PCOS), but higher is not always better.
• While we cannot reliably increase the number of eggs remaining, research suggests lifestyle and targeted therapies may help support egg quality.
• AMH should always be interpreted alongside your age, ultrasound findings, hormone testing, medical history, and your partner’s fertility—not as a single laboratory number.

About the Author

Dr. Kiera Lane, N.M.D., MSAc., L.Ac., Dipl. Ac., FABORM is the Medical Director and Founder of Arizona Natural Medicine® in Chandler, Arizona and an integrative fertility and wellness expert.

Dr. Lane has spent more than two decades helping individuals and couples navigate fertility concerns using an integrative approach that combines conventional fertility evaluation with naturopathic medicine, nutrition, acupuncture, lifestyle medicine, and individualized treatment.

She is the author of Complete Fertility Solutions for Natural Fertility and Improving IVF Success Everyone Should Know and Fertility Affirmations for the Body, Mind, and Spirit: 365 Days of the Year.

References & Further Reading

1. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020;114(6):1151-1157. ASRM Guideline
2. Steiner AZ, Pritchard D, Stanczyk FZ, et al. Association between biomarkers of ovarian reserve and infertility among older reproductive age women. JAMA. 2017;318(14):1367-1376. PubMed
3. La Marca A, Sighinolfi G, Radi D, et al. Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113-130. PubMed
4. Landersoe SK, Petersen KB, Sørensen AL, et al. Ovarian reserve markers after discontinuing long-term use of combined oral contraceptives. Reprod Biomed Online. 2020;40(1):176-186. PubMed
5. Plante BJ, Cooper GS, Baird DD, Steiner AZ. The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years. Menopause. 2010;17(3):571-576. PubMed
6. Moy V, Jindal S, Lieman H, Buyuk E. Obesity adversely affects serum anti-Müllerian hormone (AMH) levels in Caucasian women. J Assist Reprod Genet. 2015;32(9):1305-1311. PubMed
7. Muzii L, Di Tucci C, Di Feliciantonio M, et al. Antimüllerian hormone is reduced in the presence of ovarian endometriomas: a systematic review and meta-analysis. Fertil Steril. 2018. PubMed
8. Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(9):3146-3154. PubMed
9. Somigliana E, Berlanda N, Benaglia L, Viganò P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril. 2012;98(6):1531-1538. PubMed
10. Moridi I, Chen A, Tal O, Tal R. The association between vitamin D and anti-Müllerian hormone: a systematic review and meta-analysis. Nutrients. 2020;12(6):1567. PubMed
11. Xu Y, Nisenblat V, Lu C, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol. 2018;16:29. PubMed
12. Xu L, Hu C, Liu Q, et al. The effect of dehydroepiandrosterone (DHEA) supplementation on IVF or ICSI: a meta-analysis of randomized controlled trials. Geburtshilfe Frauenheilkd. 2019;79(7):705-712. PubMed
13. Qin JC, Fan L, Qin AP. The effect of dehydroepiandrosterone supplementation on women with diminished ovarian reserve in IVF cycle: evidence from a meta-analysis. J Gynecol Obstet Hum Reprod. 2017;46(1):1-7. PubMed
14. Schwarze JE, Canales J, Crosby J, et al. DHEA use to improve likelihood of IVF/ICSI success in patients with diminished ovarian reserve: a systematic review and meta-analysis. JBRA Assist Reprod. 2018;22(4):369-374. PubMed
15. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2023;38(9):1655-1679. PubMed
16. Liu S, et al. Clinical efficacy of acupuncture for diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2023;14:1136121. PubMed
17. Fan et al. The efficacy of acupuncture on endometrial receptivity in infertile women: an overview of systematic review and meta-analysis. 2025. PubMed
18. Xu L, Liang X, Wang W, et al. Clinical evidence of acupuncture for infertile women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2026;17:1840157. PubMed